QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 thinkequity-initiates-coverage-on-biovie-with-buy-rating-announces-price-target-of-3

ThinkEquity analyst Ashok Kumar initiates coverage on BioVie (NASDAQ:BIVI) with a Buy rating and announces Price Target of $3.

 biovie-presents-protocol-design-of-upcoming-sunrise-pd-phase-2-trial-of-bezisterim-in-patients-with-early-parkinsons-disease-at-atmrd-2024

SUNRISE-PD to evaluate the effect of bezisterim (NE3107) on motor and non-motor symptoms in ~60 patients with Parkinson's d...

 biovies-bezisterim-full-dataset-from-phase-2a-trial-in-parkinsons-disease-patients-experienced-significant-improvements-in-both-non-motor-symptoms-and-motor-control-while-placebo-treated-patients-worsened

Full Dataset from Phase 2a trial in Parkinson's Disease suggest patients treated with bezisterim experienced significant im...

 biovie-presents-data-showing-potential-for-bezisterim-to-reduce-inflammation-and-restore-homeostasis-in-a-manner-correlated-with-alzheimers-disease-and-biomarker-endpoints

"Bezisterim" has been approved as the non-proprietary name for NE3107 Data shows how bezisterim may be restoring homeos...

 biovie-to-present-data-showing-how-ne3107-potentially-restores-homeostasis-via-specific-genes-associated-with-dementia-metabolism-and-inflammation

BioVie Inc. (NASDAQ:BIVI), ("BioVie" or the "Company"), a clinical-stage company developing innovative drug the...

 crude-oil-down-over-1-quoin-pharmaceuticals-shares-spike-higher

U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to ...

 why-bitdeer-technologies-shares-are-trading-higher-by-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported prelimina...

 gold-gains-1-joann-shares-plummet

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.2% on Monday. The Dow traded down ...

 why-biovie-bivi-shares-are-down-40

BioVie shares are trading lower by 42% during Monday's session. The company announced the pricing of its public offering.

 dow-falls-over-100-points-sea-posts-upbeat-sales

U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market openin...

 why-biovie-shares-are-trading-lower-by-around-42-here-are-20-stocks-moving-premarket

Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public ...